Feb 24 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* HY UNDERLYING EBITDA $39.9M, DOWN 16%
* HY REPORTED REVENUE $208.8 MILLION VERSUS $227.2 MILLION
Feb 24 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* HY UNDERLYING EBITDA $39.9M, DOWN 16%
* HY REPORTED REVENUE $208.8 MILLION VERSUS $227.2 MILLION